Inhibikase Therapeutics, Inc.
IKTNASDAQHealthcare● Active
$1.62
$-0.01(-0.61%)
Market Cap$213892870
P/E Ratio—
52W High$2.26
52W Low$1.33
Inhibikase Therapeutics, Inc. (IKT) Stock Splits
No forward or reverse splits on record since IPO — details below.
FMP · IKT · as of Jun 8, 2026
Key split metrics
—
Inhibikase Therapeutics, Inc. (IKT) has been publicly traded since Dec 23, 2020 with no forward or reverse splits on record.
About stock split history
Inhibikase Therapeutics, Inc. (IKT) has never undergone a stock split since going public.
Frequently asked questions
Inhibikase Therapeutics, Inc. (IKT) has never split its stock since going public.
IKT stock split historyhas IKT ever stock splitno stock split since IPO
Data: Financial Modeling Prep · Updated daily · For informational purposes only, not investment advice.